Manufacturing strategies for Biosimilar: A case of continuous capture

Logo
Presented by

Solomon Alva, Biocon & Presented by Yvan Ruland, PhD, Technology Director, Asia/Pacific operations, Novasep Asia

About this talk

Presented By Solon Alva Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited Continuous manufacturing is an emerging technology in biopharmaceutical industry. The focus of this webinar is a case-study on the benefits of continuous Protein A capture on productivity, capacity utilization and buffer consumption. The potential challenges of adopting the technology such as its integration with cell culture and low pH incubation step has been discussed. There is promise of this technology as an effective platform, and potential of additional savings when considering new generation Protein A resins and in-line concentration technologies. Followed by Yvan Ruland, PhD, Technology Director, Asia/Pacific operations, Novasep Asia

Related topics:

More from this channel

Upcoming talks (25)
On-demand talks (303)
Subscribers (29779)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.